6-Demethylchlortetracycline (6-DCT), a tetracycline antibiotic produced by Streptomyces aureofaciens, is a crucial precursor employed for the semi-synthesis of tigecycline, minocycline, and amadacyclin (PTK 0796). In this study, the 6-DCT biosynthetic gene cluster (BGC) was cloned from genomic DNA of a high 6-DCT-producing strain, S. aureofaciens DM-1, using the transformationassociated recombination method. An extra copy of the 6-DCT BGC was introduced and integrated into the chromosome of S. aureofaciens DM-1. Duplication of the 6-DCT BGC resulted in a maximum increase of the 6-DCT titer by 34%.
Introduction
Streptomyces aureofaciens is a Gram-positive actinomycete that produces four tetracycline antibiotics, chlortetracycline, tetracycline, 6-demethylchlortetracycline (6-DCT), and 6-demethyltetracycline [1] . 6-DCT was first reported by McCormick in 1957, and it has become an important antibiotic, exhibiting activity against a wide range of Gram-positive and Gram-negative bacteria, including organisms such as Chlamydiae, Mycoplasma, and Rickettsiaceae. Furthermore, 6-DCT is also an industrial material for the production of semisynthetic tetracyclines [2, 3] . Thus far, the highest-yielding industrial producer of 6-DCT was obtained by continuous 'random mutagenesis and screening' procedures, and further yield improvement using this strategy is limited. However, with a better understanding of the synthesis and regulation of natural secondary metabolites in Streptomyces and the development of various molecular biological tools, metabolic engineering has been developed as an effective approach to improve the production of various secondary metabolites.
The genes involved in the synthesis of secondary metabolites are usually present in a linear cluster. Overexpression of synthetic genes individually or in groups has been demonstrated to enhance the yield of target products. In recent years, many antibiotic biosynthetic gene clusters (BGCs) have been cloned, either for the improved production of antibiotics or for the investigation of functional genes [4] [5] [6] . For instance, the production of nikkomycin X and nikkomycin Z was increased by 4-and 1.8-fold, respectively, after introduction of an extra copy of the nikkomycin BGC into the genome of a producer strain [7] . However, large-size DNA region cloning usually depends on genomic DNA library construction, which is time-consuming and requires screening to identify the desired cosmid/fosmid clones. Hence, the cloning of BGCs is a challenging task. However, homologous recombination-assisted cloning approaches, such as RecE-mediated homologous recombination [7] [8] [9] and transformation-associated recombination (TAR) [10] [11] [12] , have been developed and demonstrated to be effective approaches for direct cloning of targeted gene clusters from genomic DNA.
Taking advantage of the highly efficient recombination capacity of Saccharomyces cerevisiae, TAR cloning is an innovative approach useful for rapid capturing and heterologous expression of large chromosomal regions [13] . It uses the yeast cell as a host, in which a DNA target of interest and a linearized TAR cloning vector preloaded with homologous regions form a large circularized plasmid via in vivo homologous recombination [14] . The genetic target of interest can be readily amplified, propagated with the replication of the TAR cloning vector, and can be easily prepared for any use, such as homologous expression or reprogramming of secondary metabolite BGCs.
The ctc gene cluster which encodes chlortetracycline was initially obtained by cosmid library construction and screening. Recently, Zhu et al. [15] identified a 43.9-kb ctc gene cluster by screening a fosmid library of the chlortetracycline industrial producer S. aureofaciens F3. Our previous work demonstrated the high similarity between the 6-DCT BGC of S. aureofaciens DM-1 (Genebank accession number: CP020567) and the ctc gene cluster of S. aureofaciens F3 (Genebank accession number: HM627755.1).
Here we report the implementation of TAR for direct capture of the 6-DCT BGC from S. aureofaciens DM-1 genomic DNA. A strain with a duplicated 6-DCT BGC was obtained by delivering a ФC31-int-based cluster plasmid into S. aureofaciens DM-1. Overexpression of the integrated 6-DCT biosynthetic cluster led to a 34% increase in 6-DCT production.
Materials and Methods

Strains, plasmids, and growth conditions
The strains and plasmids used in this study are listed in Table 1 . Streptomyces aureofaciens DM-1 and its derivatives were grown at 30°C on ISP2 medium (yeast extract 4.0 g/l, malt extract 10.0 g/l, glucose 4.0 g/l, and agar 20 g/l) for spore preparation. Strain DM-1 was cultivated in liquid ISP2 medium (without agar) on an orbital shaker (250 rpm) at 28°C for total DNA isolation.
Escherichia coli strains EPI300 and DH5α were used for routine DNA cloning. Escherichia coli ET12567/pUZ8002 was used for conjugal transfer between E. coli and S. aureofaciens DM-1.
Escherichia coli strains were grown at 37°C in Luria-Bertani medium supplemented with necessary antibiotics. Kanamycin (Kan, 50 μg/ml), apramycin (Apr, 50 μg/ml), chloramphenicol (25 μg/ml), and nalidixic acid (15 μg/ml) were used for the selection of E. coli or Streptomyces recombinant strains.
Reagents and enzymes
PCR products and restriction enzyme digestion products were purified using an AxyPrep DNA Gel Extraction Kit or an Agarose Gel DNA Extraction Kit (Axygen, Union City, USA). Restriction enzymes were purchased from Thermo Scientific (Waltham, USA). Oligonucleotides were obtained from GenScript (Nanjing, China). Plasmids pCAPDM and pCAPDMA were isolated and purified using an E.Z.N.A.s BAC/ PAC DNA Kit (Omega Bio-Tek, Winooski, USA). Other reagents used in TAR cloning experiments are described in a previous report [12] .
Preparation of genomic DNA fragments for TAR Streptomyces aureofaciens DM-1 was grown in ISP2 liquid medium. Genomic DNA was isolated by standard procedures [19] . Approximately 150 μg of genomic DNA was digested with 200 U of NsiI/MfeI, which does not cut the 6-DCT gene cluster, in an overnight reaction at 37°C. The digested genomic DNA fragments were precipitated and washed with 70% ethanol. The resulting DNA pellet was dissolved in 100 μl of 20% Tris-EDTA buffer (2 mM TrisHCl and 0.2 mM EDTA, pH 8.0).
Construction of the gene cluster capture vector pCAPLR
The primers Rarms-long and Rarmas-long and Larms-long and Larmas-long were used to amplify two homologous arms by PCR analysis (1468 and 1471 bp long, respectively) corresponding to flanking regions of the 6-DCT BGC from DM-1 genomic DNA. The primer Rarms-long contains a PmeI restriction site. The homologous Table 1 . Bacterial strains and plasmids used in this study
Strain or plasmid
Relevant features Source
Host strain for in vivo homologous recombination: MAT alpha, his3-D200, trp1-D1, ura3-52, lys2, ade2-101, met14, psi + cir0
The parental strain that produces 6-DCT NORTH CHINA PHARMACEUTICAL CO., LTD DM-1-10 DM-1 containing plasmid pCAPDMA This study DM-1-11 DM-1 containing plasmid pCAPA This study Plasmids pCAP01 ARSH4/CEN6, pUC ori, aph(3)II, φC31 int-attP, oriT (RP4)
pUC19ori, ΦC31 int/attP, aac(3)IV, lacZα, and oriT RK2 This study arms were then cloned simultaneously into KpnI-digested pCAP01, yielding the gene cluster-specific capture vector pCAPLR. Prior to direct TAR cloning, the 'circular' construct was digested with PmeI, generating a linear capture vector flanked by 1.5-kb capture arms at each end.
Direct cloning of the 6-DCT gene cluster using TAR Direct TAR cloning of the 6-DCT gene cluster from genomic DNA was performed similarly to the protocol previously described [11, 12] . Streptomyces cerevisiae strain VL6-48 was grown in 50 ml YPD medium supplemented with adenine (100 mg/l) at 30°C with shaking until the OD 600 nm reached 0.6-1.0. The preparation of spheroplasts was carried out as reported previously [12] . After incubation at 30°C for 40 min, the spheroplasts were transformed with 2-3 μg of DM-1 genomic DNA fragment and 1 μg linearized 6-DCT gene cluster-specific capture vector pCAPLR. The transformed spheroplasts were mixed with 10 ml SD-Trp top agar (SD-Trp containing 3% agar), equilibrated at 50°C and overlaid on SD-Trp agar. The plates were incubated at 30°C for 3 days. Transformants that appeared on the plates were picked with toothpicks and transferred onto new SD-Trp agar plates, which were incubated for 3 days at 30°C. To screen for the directly cloned 6-DCT gene cluster in S. cerevisiae clones, genotyping of multiple transformants was carried out by colony PCR using primers Halo-up/Halo-down, Larm up-4/Larm down-4, and Rarm up-4/Rarm down-4, respectively. Cells confirmed by colony PCR were first cultivated in 4 ml YPD medium and collected by centrifugation for 5 min at 1000 g, and were then suspended in 1 ml SPE solution containing 10 μl Zymolyase-20T (Supplementary Table S1 ) and incubated at 37°C for 1 h before extraction of plasmids. Then, plasmids bearing the 6-DCT gene cluster were obtained using an E.Z.N.A.s BAC/PAC DNA Kit, and subsequently transferred into E. coli EPI300 by electroporation to facilitate the harvest and sequencing of the 6-DCT BGC plasmids. After electroporation, Kan r E. coli clones were randomly picked and analyzed by colony PCR. The plasmids purified from Kan r E. coli transformant colonies were confirmed by PCR screening using primers listed in Supplementary Table S2 and restriction analysis with BamHI. The yielded construct was designated as pCAPDM. To conveniently select both E. coli ET12567 and Streptomyces recombinants, we added an Apr resistance gene (aac(3)IV, Apr r ) to pCAPDM. The aac(3)IV gene was first amplified from plasmid pSET152 using primers apra-pcaPs/apra-pcaPas, and then ligated into NheI-digested pCAPDM using the One Step Cloning Kit (Vazyme Biotech Co., Ltd, Nanjing, China), yielding pCAPDMA. All constructed vectors were confirmed by restriction enzyme digestion analysis and DNA sequencing. The plasmids pCAPDMA and the control plasmid pCAPA were introduced individually into the parental strain S. aureofaciens DM-1 through conjugal transfer, generating the corresponding overexpression strains DM-1-10 and DM-1-11 ( Table 1) . Strain DM-1-11 was used as a negative control.
Fermentation of S. aureofaciens and analysis of 6-DCT production
Streptomyces aureofaciens strains were grown on ISP2 medium at 30°C for 6 days and then inoculated into seed medium [g/l: corn starch 30, soybean flour 30, peptone 5, yeast extract 2, soybean oil 16, (NH 4 ) 2 SO 4 2, KH 2 PO 4 1.5, CaCO 3 10] . The pH was adjusted to 5.4-5.6 prior to CaCO 3 addition and sterilization. For S. aureofaciens fermentation in Erlenmeyer flasks, the cultures were incubated at 28°C in 30 ml of seed medium in 250-ml Erlenmeyer flasks on an orbital shaker (250 rpm). After 46-48 h, 3 ml of preculture was inoculated into 30 ml of fermentation medium [g/l: corn starch 40, glucose 10, soybean flour 30, soybean oil 12, corn steep liquor 4, L-Lysine hydrochloride 8, NaCl 4, (NH 4 ) 2 SO 4 3, CaCO 3 10]. The pH was adjusted to 6.0 prior to CaCO 3 addition and sterilization.
For the analysis of 6-DCT production, solid oxalic acid was used to adjust the pH of the fermentation samples to 1.8-2.0, then the samples were extracted with an equal volume of acetone for 1 h. The culture filtrates were harvested by centrifugation and analyzed by HPLC (Waters 2487; Milford, USA) using a YMC-Triart C18 column (4.6 mm × 250 mm, 5 μm). For HPLC detection, a mixture of water (containing 0.01 M oxalic acid and 0.08 M ammonium oxalate):acetonitrile:methanol (10:3:2; v/v/v) was used as the mobile phase, with a flow rate of 1.0 ml/min. The eluate was monitored at 350 nm, and the column temperature was 30°C. Production of 6-DCT was calculated from a standard curve.
Results
TAR cloning of the 6-DCT BGC
The 6-DCT BGC spans a 43.5-kb region containing 36 open reading frames (ORFs), 28 of which are involved in 6-DCT biosynthesis. It was found that unique restriction sites MfeI and NsiI flanked the 6-DCT BGC. They were chosen to digest the genomic DNA to obtain a nucleotide fragment containing the entire BGC. The plasmid pCAP01 contains three distinct modules. One module is necessary for propagation in E. coli and S. cerevisiae, another module is necessary for conjugal transfer between the E. coli donor and Streptomyces, as well as ФC31-derived integrase module useful for integration into the attB site that is ubiquitous in the Streptomyces genome [18] . Two regions inside the MfeI and NsiI cleavage sites, corresponding to the upstream and downstream regions of the 6-DCT BGC, were amplified by PCR and cloned into pCAP01 to generate the pathway-specific capture vector pCAPLR (Fig. 1) . pCAPLR was confirmed by restriction enzyme digestion ( Fig. 2A) . After transformation of S. cerevisiae VL6-48 spheroplasts with the linearized vector and NsiI/MfeI restriction enzyme-digested genomic DNA, 4 of the 164 S. cerevisiae transformants were identified as positive clones by PCR using specific primers (Fig. 2B) . The plasmids isolated from BGC-positive yeast colonies were transferred into E. coli EPI300 by electroporation for amplification. The 6-DCT BGC cloning plasmid pCAPDM extracted from E. coli EPI300 was confirmed by PCR (Fig. 2C) and restriction digestion (Fig. 2D) . The Kan resistance gene of pCAPDM was replaced by an Apr resistance gene (aac(3)IV) to produce pCAPDMA, which facilitated screening after conjugation with Streptomyces spores.
Duplication of the 6-DCT BGC in S. aureofaciens DM-1 pCAPDMA was introduced into the 6-DCT-producing parental strain S. aureofaciens DM-1 by conjugative transfer. The empty vector pCAPA was separately introduced to generate control cells. The resulting transformants, designated as S. aureofaciens DM-1-10 (pCAPDMA) and DM-1-11 (pCAPA), were inoculated on ISP2 plates supplemented with Apr for clone purification and fermentation.
These transformants were confirmed by PCR amplification using the pCAP01 skeleton-specific primers blatgas/Rarms-long and pset152 up/Larmas-long to avoid signals generated from the original 6-DCT BGC. The plasmid pCAPDMA and genomic DNA of strain DM-1-11 were used as positive and negative controls, respectively. Fragments of 2.0 kb and 2.5 kb were amplified from genomic DNA of the six transformants and plasmid pCAPDMA, but not from S. aureofaciens DM-1-11 (Fig. 3) , demonstrating that pCAPDMA was successfully integrated into the genome of S. aureofaciens. One of the S. aureofaciens DM-1-10 clones was chosen for further investigation.
Overproduction of 6-DCT by overexpressing the 6-DCT BGC in S. aureofaciens DM-1
The 6-DCT production of S. aureofaciens DM-1-10, which contains a duplicated 6-DCT BGC, was assessed by fermentation. In parallel, parental S. aureofaciens DM-1 and its derivative DM-1-11 (with the empty plasmid pCAPA integrated into the DM-1 genome) were used as controls. Fermentation broth of the S. aureofaciens strains was sampled at different time points (3, 4, 5, 6, 7, and 8 days) and their 6-DCT production was analyzed by HPLC. Introduction of an extra copy of the BGC (in strain DM-1-10) resulted in a 34% increase in 6-DCT production, from 489 mg/l to 655 mg/l (Fig. 4A) . Strain DM-1-11 exhibited a slight increase in 6-DCT production over DM-1 (489-518 mg/l) (Fig. 4A) , possibly due to an unknown vector effect.
To investigate the production stability of the double-cluster recombinant strain, DM-1-10 was incubated in ISP2 medium without Apr selection. After 5 subcultures, 12 colonies were randomly selected and then cultured in medium supplemented with 50 μg/ml Apr for 5 days. All of them were Apr-resistant and able to produce approximately 34% increase in the production of 6-DCT compared with the parental strain DM-1 (Fig. 4B) . These results demonstrated that the transformants harboring one extra copy of 6-DCT BGC were genetically stable. Figure 1 . Schematic illustration of direct cloning of the 6-DCT BGC using the TAR method The relevant genomic DNA fragment of S. aureofaciens DM-1 consists of 36 ORFs; genomic DNA was digested with NsiI/MfeI to generate the complete 6-DCT BGC-containing DNA fragment. Spheroplasts of S. cerevisiae VL6-48 were transformed with the enzymatically digested genomic DNA mixture and the 6-DCT pathway-specific capture vector pCAPLR, which was linearized by PmeI before TAR cloning. In yeast cells, homologous recombination occurred between 1.5-kb arms in the vector pCAPLR and the genomic DNA fragment, and thus the 44-kb genomic region containing the 6-DCT locus was directly captured into the vector, yielding the replicable circular construct pCAPDM. 
Discussion
Yield improvement of secondary metabolites, especially medically and industrially important compounds, is one of the most significant goals for pharmacy as well as basic research. Although numerous methods have been developed to improve production, such as optimizing promoters, reprograming transcriptional regulation, and overexpression of key pathway genes [20] , most approaches have limitations. Due to the ubiquity of the phage ФC31-derived attB site in actinomyces genomes, duplication of whole biosynthetic pathways has been proved to be an feasible and effective strategy to increase the yields of secondary metabolites [7, [21] [22] [23] . Additionally, plasmid cloning of BGCs has many potential applications, including rapid refactoring of known BGCs and heterologous expression of large biosynthetic loci for the exploration of novel secondary metabolites [17] in tractable hosts [9, 24, 25] . Random DNA library construction, PCR amplification [26] , and direct DNA synthesis are the generally used cloning methods to obtain large BGCs. However, these approaches have various limitations. For instance, random library cloning relies on laborious library construction and screening. PCR amplification and assembly procedures are expensive and require deep sequencing to confirm the fidelity. Recently reported tools, such as Red/ET technology [8] , Gibson assembly [27] , and TAR [10, 11, 25] , offer direct cloning of targeted gene clusters from genomic DNA. In this study, we successfully employed restriction enzyme digestion-assisted TAR technology to clone the entire 6-DCT BGC into an integrative vector, pCAP01. The resulting plasmid was integrated into the chromosome of S. aureofaciens DM-1, thus leading to overexpression of the entire 6-DCT BGC.
It has been demonstrated that cutting near the targeted genomic region increases the efficiency of TAR cloning [28] . However, restriction enzyme digestion-assisted TAR cluster capture still has its drawbacks. Unique restriction enzyme sites which flank the cluster of interest and do not occur in the target region are usually unavailable or are far away from the ends of the target region, especially in larger clusters. A recently developed CRISPR-Cas9-assisted TAR method explored the precise double strand breaking ability of sgRNA-guided Cas9 to cut the target region [14] . With the in vitro enzyme reactions, Cas9 is able to cut at almost any position of interest when provided with reprogrammed sgRNA, which will markedly reduce the size of target fragments for TAR cloning and facilitate the capture procedures.
In summary, we demostrated that the 6-DCT production of the recombinant strain with the duplicated BCG was increased by 34% relative to the parental strain, suggesting that overexpression of the whole cluster could improve 6-DCT synthesis. Based on the current cluster plasmid, many metabolic engineering strategies, such as manipulation of transcriptional regulators [20, 29] , increasing precursor supplies [30] , optimizing promoters of key pathway genes [31] , and enhancing the transcription level of genes encoding antibiotic transporters to reduce end-product toxic effects and feedback inhibition [32] , may be combined to hopefully further optimize 6-DCT biosynthesis.
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Supplementary data are available at Acta Biochimica et Biophysica Sinica online. . 6-DCT production and production stability of a S. aureofaciens strain containing an extra copy of the 6-DCT BGC (A) 6-DCT production profiles of strain DM-1-10 compared with DM-1 (parental) and DM-1-11 (negative control). Fermentation samples were collected at six time points, and fermentations were performed in triplicate. (B) Production stability of DM-1-10 in five continuous passages. Fermentation samples were taken on the eighth day, and fermentations were performed in triplicate.
